BNP Paribas Financial Markets
NBTX

BNP Paribas Financial Markets’s Nanobiotix NBTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Buy
4,044
+485
+14% +$18K ﹤0.01% 4349
2026
Q1 		$110K Sell
3,559
-41
-1% -$1.08K ﹤0.01% 4330
2025
Q4 		$83.2K Buy
3,600
+3,200
+800% +$69.9K ﹤0.01% 4457
2025
Q3 		$7.56K Sell
400
-361
-47% -$3.07K ﹤0.01% 5052
2025
Q2 		$3.6K Buy
761
+100
+15% +$387 ﹤0.01% 4990
2025
Q1 		$2.34K Buy
+661
New +$2.28K ﹤0.01% 4966

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

BNP Paribas Financial Markets's NBTX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Nanobiotix (NBTX) stake by 14% in Q2 2026, buying an estimated $18K and bringing the position to 4,044 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #4349.

BNP Paribas Financial Markets first reported a position in NBTX in Q1 2025 and has held it in 6 quarters since. 11 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • BNP Paribas Financial Markets held 4,044 shares of Nanobiotix worth $152K as of Q2 2026.
  • BNP Paribas Financial Markets bought 485 Nanobiotix shares in Q2 2026, an estimated $18K.
  • Nanobiotix made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4349 holding.
  • BNP Paribas Financial Markets first reported a position in Nanobiotix in Q1 2025 and has held it in 6 quarters since.
  • 11 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.